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ERK, AP-1 and Nrf2 and block HO-1 protein expression. 
The present study, furthermore, demonstrated arsenic-
induced expression of arsenic response protein 2 (ARS2) 
that was regulated by p38 MAPK, ERK and NF-κB. To 
our knowledge, this is the first report showing that ARS2 
involved in arsenic-induced nephrotoxicity, while TMP 
pretreatment prevented such an up-regulation of ARS2 
in HK-2 cells. Given ARS2 and HO-1 sharing the similar 
regulation mechanism, we speculated that ARS2 might also 
mediate cell survival in this procession. In summary, our 
study highlighted a role of HO-1 in the protection against 
arsenic-induced cytotoxicity downstream from the primary 
targets of TMP and further indicated that TMP may be used 
as a potential therapeutic agent in the treatment of arsenic-
induced nephrotoxicity.
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AKI  Acute kidney injury
ARS2  Arsenic response protein 2
As  Arsenic
Bay  Bay 11-7082
CKD  Chronic kidney disease
DHE  Dihydroethidium
FACS  Fluorescence-activated cell sorter
HO-1  Heme oxygenase-1
MAPK  Mitogen-activated protein kinase
Nrf2  Nuclear factor erythroid derived-2
NAC  N-acetylcysteine
Abstract Our recent study demonstrated that sodium 
arsenite at a clinically relevant dose induced nephrotoxicity 
in human renal proximal tubular epithelial cell line HK-2, 
which could be inhibited by natural product 2,3,5,6-tetra-
methylpyrazine (TMP) with antioxidant activity. The pre-
sent study demonstrated that arsenic exposure resulted in 
protein and enzymatic induction of heme oxygenase-1 
(HO-1) in dose- and time-dependent manners in HK-2 
cells. Blocking HO-1 enzymatic activity by zinc protopor-
phyrin (ZnPP) augmented arsenic-induced apoptosis, ROS 
production and mitochondrial dysfunction, suggesting a 
critical role for HO-1 as a renal protectant in this proces-
sion. On the other hand, TMP, upstream of HO-1, inhib-
ited arsenic-induced ROS production and ROS-dependent 
HO-1 expression. TMP also prevented mitochondria dys-
function and suppressed activation of the intrinsic apoptotic 
pathway in HK-2 cells. Our results revealed that the regu-
lation of arsenic-induced HO-1 expression was performed 
through multiple ROS-dependent signal pathways and the 
corresponding transcription factors, including p38 MAPK 
and JNK (but not ERK), AP-1, Nrf2 and NF-κB. TMP 
inhibited arsenic-induced activations of JNK, p38 MAPK, 
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NF-κB  Nuclear factor-κB
PARP  Poly ADP-ribose polymerase
PI  Propidium iodide
ROS  Reactive oxygen species
SB  SB203580
SDH  Sucinate dehydrogenase
SP  SP600125
TMP  Tetramethylpyrazine
TUNEL  Terminal deoxynucleotidyl transferase-mediated 
dUTP-biotin nick end labeling
U0  U0126
ZnPP  Zinc protoporphyrin
Introduction
Arsenic (As) is an important environmental contaminant 
affecting more than 140 million people worldwide through 
contaminated drinking water (Rodriguez-Lado et al. 2013). 
Recent epidemiologic studies in a rural US population, in 
some regions of China and especially in Bangladesh sug-
gest arsenic is a major risk factor for kidney disease (Chen 
et al. 2011; Zheng et al. 2013). Kidney is one of the tar-
geted organs of arsenic cytotoxicity that could cause renal 
dysfunction, proteinuria and chronic kidney disease (CKD) 
(Yu et al. 2013; Michael 2013; Ruiz-Hernandez et al. 2015; 
Zheng et al. 2014; Chen et al. 2014). Our recent study 
demonstrated that sodium arsenite at a clinically relevant 
dose induced cytotoxicity in human renal proximal tubu-
lar epithelial cell line, HK-2, which served as a repre-
sentative cell model for exposures of the human kidney to 
As, drug-induced nephrotoxicity and acute kidney injury 
(Huang et al. 2015; Peraza et al. 2003, 2006; Wang et al. 
2013b). Furthermore, our recent results indicated that such 
a nephrotoxicity was associated with a dramatic increase in 
intracellular ROS production, mitochondrial dysfunction, 
inflammation, apoptosis and autophagy (Gong et al. 2014). 
However, the precise molecular mechanisms responsible 
for arsenic nephrotoxicity remain largely unclear.
The inducible heme oxygenase-1 (HO-1) could exhibit 
anti-apoptotic, anti-oxidative and anti-inflammatory prop-
erties and thus be a renal protectant in multiple kidney 
injuries, such as acute kidney injury (AKI) induced by 
ischemia or nephrotoxicity induced by cisplatin and con-
trasting solutions (Chang et al. 2014; Miyagi et al. 2014). 
The critical role of HO-1 has also been reported in several 
organ injuries (Wang and Dore 2007; Billings et al. 2014). 
Given that HO-1 also has been identified as a response 
biomarker for arsenic exposure in various types of cells, 
we were very interested: (1) What is the role of HO-1 in 
As-induced nephrotoxicity (Gong et al. 2014) at clini-
cally relevant doses? (2) What are the intricate molecular 
mechanisms involving in the regulation of HO-1 induction 
during As nephrotoxicity?
Furthermore, we have previously identified 2,3,5,6-tetra-
methylpyrazine (TMP), a compound extracted from the 
Chinese medicinal plant Ligusticum wallichi (Chuanxiong) 
as a protective agent against arsenic nephrotoxicity, which 
could attenuate ROS production, inflammation and cell 
death (Gong et al. 2014). One of the main aims of the cur-
rent study was to further elucidate a potential relationship 
between HO-1 production and the renal protection by anti-
oxidant TMP in arsenic nephrotoxicity, which is not well 
understood.
Arsenic response protein 2 (ARS2, also known as Srrt) 
was first isolated as a gene product conferring resistance 
to arsenite and arsenate in Ass/S5 cell line (Rossman and 
Wang 1999). Based on the very limited published data, 
ARS2 has been shown to be essential for the development 
of plants and mammals and also acts as a transcriptional 
regulator of Sox2 in neural stem cell (Kiriyama et al. 2009; 
Wilson et al. 2008; Andreu-Agullo et al. 2012). However, 
the precise biological functions of ARS2 in mammalian are 
largely unknown (Wilson et al. 2008; Andreu-Agullo et al. 
2012). The previous work from our laboratory has shown 
an up-regulation of ARS2 expression in human neural stem 
cell after arsenic exposure (Ivanov and Hei 2013), which 
suggested that ARS2 might be involved in arsenic-induced 
cytotoxicity and supported the previous suggestion that 
ARS2 has essential functions (Wilson et al. 2008). How-
ever, the signaling mechanism regulating ARS2 induction 
is still unclear, and a role of ARS2 in arsenic nephrotoxicity 
has not been reported so far.
In the present study, we have further investigated the 
potential relationships between HO-1 induction, TMP-
mediated renal protection and ARS2 expression in the sup-
pression of arsenic nephrotoxicity.
Materials
All chemicals were purchased from Sigma (St. Louis, 
MO, USA) unless otherwise stated. NF-κB inhibitor Bay 
11-7082 (Bay), MAPK p38 inhibitor SB203580 (SB) and 
ERK inhibitor U0126 (U0) were obtained from Calbio-
chem (La Jolla, CA, USA), and JNK inhibitor SP600125 
(SP) was obtained from Biomol (Plymouth Meeting, PA, 
USA).
Cell culture and treatment
The human proximal tubular cell line HK-2 (Ameri-
can Type Culture Collection, Manassas, VA, USA) 
was grown in culture medium (keratinocyte serum-free 
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medium + 5 ng/ml epidermal growth factor and 50 μg/
ml bovine extract + 100 U/ml penicillin and 100 μg/
ml of streptomycin) at 37 °C and 5 % CO2 humidified 
environment.
The next stock solutions were prepared: 50 mM sodium 
arsenite, antioxidant N-acetylcysteine (NAC, 10 mM), 
TMP (50 μM, 100 μM) in PBS, NF-κB inhibitor Bay 
(5 μM), MAPK p38 inhibitor SB (10 μM), ERK inhibi-
tor U0 (10 μM) and JNK inhibitor SP (10 μM) in DMSO, 
and HO-1 inhibitor zinc protoporphyrin (ZnPP, 2 μM) in 
methanol. NAC, TMP and other inhibitors were added into 
media 30 min before As.
Intracellular ROS detection
Dihydroethidium (DHE, Invitrogen, Eugene, OR) method 
to detect intracellular superoxide production was used. 
After 24-h As treatment, cells were exposed to 2 μM DHE 
45 min at 37 °C in the dark and then washed twice with 
PBS. Finally, fluorescence-activated cell sorter (FACS) 
analysis was performed (Becton–Dickinson, Franklin 
Lakes, NJ) using the CellQuest program. Samples were 
analyzed in triplicate, and all experiments were repeated 
three times independently.
Analyses of apoptosis by PI staining and FACS assay 
and TUNEL staining
Apoptotic cells were identified by diminished DNA content 
in the sub-G1 population of normal diploid cells by FACS 
assay after staining with propidium iodide (PI) (Gong et al. 
2010). Approximately 20,000 counts were made for each 
sample. Finally, the data were collected and analyzed with 
CellQuest program combined with FACS machine. Apop-
totic levels were calculated by evaluating the percentage of 
events accumulated in the sub-G1 position. Samples were 
analyzed in triplicate and repeated 3 times.
To further confirm apoptotic cell death, terminal deoxy-
nucleotidyl transferase-mediated dUTP-biotin nick end 
labeling (TUNEL) staining was performed using a Click-
iT TUNEL Alexa Fluor 488 Imaging Assay (Invitrogen, 
Grand Island, NY) according to the manufacturer’s instruc-
tions except that PI replaced Hoechst 33342 to mount cells 
and label all nuclei. Stained nuclei were analyzed by a 
Nikon confocal microscope (Nikon TE200-C1) at 24 °C 
room temperature. TUNEL-positive cell numbers from 20 
different fields (a total of 2000–2500 cells) were counted to 
get an average number of cells per field.
Mitochondrial network morphology assay
Mitochondrial network morphology and activity were vis-
ualized by using MitoTracker Green (Molecular Probes, 
Invitrogen). In brief, cells were grown on 6-well plate and 
incubated with 200 nM MitoTracker Green for another 
20 min at 37 °C after 6-h As treatment. After three-time 
washes with PBS, cells were fixed with 4 % paraformal-
dehyde. Confocal fluorescence microscopy images were 
captured, and mitochondrial network morphology (tubu-
lar and non-tubular) was quantified by Image J software 
(NIH). Each treatment was randomly selected 20 non-
contiguous fields for further observation and analysis, 
generally, each field containing 20–25 cells with mito-
chondrial networks. Percentages of normal (tubular) and 
abnormal (non-tubular) mitochondrial network morpholo-
gies were counted.
Mitochondrial function assay: cytochrome c 
oxidase (Cox) and succinate dehydrogenase (SDH) 
histochemistry
Cox and SDH histochemistry were monitored as described 
previously (Gong et al. 2014). In brief, cells were cul-
tured on glass cover inside a 6-well plate. After 6 h indi-
cated treatment, cells on glass cover were allowed to dry 
at room temperature for 1 h and then followed by 15-min 
preincubation at room temperature with 1 mM CoCl2 and 
50 μl DMSO in 50 mM Tris–HCl, pH 7.6, containing 
10 % sucrose. All samples were rinsed once in PBS and 
incubated for another 3 h with incubation medium (10 mg 
cytochrome c, 10 mg of DAB hydrochloride, 2 mg of cata-
lase and 25 μl DMSO resolved in 10 ml 0.1 M phosphate 
buffer, pH 7.6). After further three-time rinse, all samples 
were mounted on warm glycerin gelatin and observed 
under Nikon LABOPHOT-2 microscope to capture images 
with SPOT Basic ™ software. Quantification of histochem-
ical staining was performed with Image J software (NIH). 
Camera light settings were standardized, and color images 
were captured with 40× objective.
Western blotting
After the various treatments, whole cell lysates were pre-
pared by incubation in RIPA buffer (Invitrogen). For 
nuclear transcription factor Nrf2 immunoblotting analysis, 
nuclear extracts were prepared using methods described 
previously (Schreiber et al. 1989). Protein concentrations 
were determined with Bio-Rad DC protein assay (Bio-Rad 
Laboratories, Calif., USA) using bovine serum albumin 
as the standard. The resulting protein samples underwent 
SDS-PAGE gel electrophoresis and were transferred to 
PVDF membrane.
The specific primary antibodies included the fol-
lowing rabbit Abs: anti-HO-1 (Enzo Life Sciences), 
anti-Bcl-xl (Cell Signaling), anti-Bax (Cell Signaling), 
anti-PARP (Cell Signaling), anti-pro-caspase-9 (Cell 
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Signaling), anti-Nrf2 (Cell Signaling), anti-JNK (Cell 
Signaling), anti-phospho-JNK (Cell Signaling), anti-
ERK (Cell Signaling), anti-phospho-ERK (Cell Signal-
ing), anti-p38 MAPK (Cell Signaling), anti-phospho-p38 
MAPK (Cell Signaling), anti-ARS2 (Santa Cruz), anti-
histone H3 (Cell signaling) and mouse anti-beta actin 
(Sigma).
Statistical analysis
The data were presented as mean ± SD for a minimum 
of three independent experiments. All comparisons were 
made using either one-way ANOVA or a two-tailed t test 
analysis depending on how many conditions were com-
pared in each experiment. One-way ANOVA was followed 
by Tukey’s post hoc test. A value of p < 0.05 was consid-
ered significant.
Results
2,3,5,6‑Tetramethylpyrazine (TMP) inhibited 
arsenic‑induced ROS‑dependent HO‑1 expression
Arsenic (As) has been identified as inducer of heme oxy-
genase-1 (HO-1) expression in many cells and tissues 
(Teng et al. 2013; Li et al. 2013). Consistent with these 
reports, we demonstrated that the induction of HO-1 pro-
tein expression was dose and time dependent in HK-2 cells 
after As exposure. Since the As dose range of 2.0–10 μM 
is successfully applied for treating acute promyelocytic 
leukemia (APL) and multiple myelomas (Ivanov and Hei 
2004, 2005; Shen et al. 1997), we therefore choose this 
dose range for our present study. Furthermore, antioxidants 
N-acetylcysteine (NAC) and TMP significantly inhibited 
arsenic-induced HO-1 expression (Fig. 1a, b). In contrast, 
Fig. 1  TMP inhibited arsenic-induced ROS-dependent HO-1 expres-
sion in HK-2 cells. a, b HK-2 cells were exposed to sodium arsenite 
at indicated doses for 3, 6 and 24 h alone or in a combination with 
either 10 mM NAC or 50–100 μM TMP. Arsenite (As) exposure 
induced HO-1 protein expression in a dose- and time-dependent man-
ner, whereas NAC and TMP pretreatment sufficiently blocked HO-1 
up-regulation. c, d Compared with 10 mM NAC, 10 μM AG, the 
inhibitor of iNOS, failed in preventing HO-1 up-regulation. β-actin 
was used as loading control. Quantitative densitometry of protein 
bands was performed. Values are mean ± SD (n = 3), (**) p < 0.01 
versus control
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aminoguanidine (AG), the iNOS inhibitor, failed in pre-
venting HO-1 up-regulation (Fig. 1c, d).
Blocking HO‑1 with ZnPP augmented As‑induced 
apoptosis and ROS production
To verify the role of HO-1 in arsenic (As) nephrotoxic-
ity, zinc protoporphyrin (ZnPP), a known inhibitor of 
HO-1 enzymatic activity, was used. Interestingly, ZnPP 
aggravated sodium arsenite (10 μM)-induced cytotoxicity 
and apoptosis that was confirmed by increased percent-
age of cells accumulated in the sub-G1 position (35.7 vs. 
12.5 %) determined by FACS analysis of PI-stained cell 
nuclei (Fig. 2a, b) and by % TUNEL-positive staining cells 
(Fig. 2c, d).
Several studies have shown that the induction of HO-1 
by As is ROS dependent (Fan et al. 2010; Teng et al. 2013). 
Our previous data have demonstrated that As exposure 
elevated ROS production in HK-2 cells (Gong et al. 2014). 
The present results demonstrate that ROS production is up-
regulated by 2.19-fold with 10 μM sodium arsenite treat-
ment. Furthermore, combined treatments with ZnPP and 
10 μM sodium arsenite resulted in a 5.35-fold increase in 
ROS production highlighting antioxidant role of HO-1 acti-
vation (Fig. 2e, f).
Fig. 2  Blocking HO-1 activity with ZnPP augmented arsenic-
induced apoptosis and ROS production. Apoptosis levels and intra-
cellular ROS production were measured 24 h after arsenic (As) treat-
ment with or without 2 μM ZnPP pretreatment of HK-2 cells. a, b 
Levels of apoptosis were calculated by evaluating the percentage of 
cells accumulated in the sub-G1 position after PI staining DNA. c, 
d Apoptosis was determined by TUNEL staining, and average per-
centages of TUNEL-positive cells were assessed in each group. e, f 
100 μM TMP and 10 mM NAC inhibited As-induced ROS genera-
tion at 24 h, while 2 μM ZnPP augmented ROS generation. Values 
are mean ± SD (n = 3), (*) p < 0.05 versus Con; (**) p < 0.01 versus 
Con; (##) p < 0.01 versus 10 μM As
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Inhibition of HO‑1 activity with ZnPP augmented 
As‑induced mitochondrial dysfunction
To further investigate the relationships among mitochon-
drial alterations, As nephrotoxicity, and blocking HO-1 
activity, mitochondrial morphology was analyzed at the 
single cell level in Mito Tracker Green-stained HK2 cells. 
As shown in Fig. 3a, a large number of cells (84.6 %) 
presented a normal (tubular) shape of mitochondrial net-
work in the control group, while a number of cells with 
the abnormal (elongated or fragmented) mitochondrial 
networks were obviously increased in 10 μM sodium 
arsenite-treated group; accordingly, the percentage of 
cells with tubular mitochondria in this group dropped to 
35.7 %. Augmented mitochondrial morphology changes 
were observed in ZnPP pretreatment group, whereas TMP 
and NAC pretreatment can effectively prevent this change 
in mitochondrial network morphology, and percentages of 
normal tubular morphology were 33.5, 72.5 and 69.8 % 
(Fig. 3b).
Our previous study (Gong et al. 2014) indicated that 
sodium arsenite induced mitochondrial dysfunction in 
HK-2 cells, shown as strong loss of mitochondrial mem-
brane potential and decreased Cox enzyme activity, which 
could be inhibited by NAC and TMP. In the present study, 
results of Cox enzyme histochemistry and mitochondrial 
membrane potential assay (data not shown) indicated that 
blocking HO-1 activity with ZnPP aggravated such a mito-
chondria dysfunction. Interestingly, the enzyme activity of 
SDH, or Complex II, encoded entirely by nuclear genome, 
was not significantly impaired by sodium arsenite treat-
ment or ZnPP (Fig. 3c–e).
Fig. 3  Blocking HO-1 with ZnPP augmented arsenic-induced mito-
chondrial dysfunction. a, b Mitochondrial morphology was deter-
mined at the single cell level in MitoTracker Green-stained HK2 
cells, and the cell number with different mitochondrial morphology 
(normal as tubular with thick arrow, elongated or fragmented with 
thin arrow) was counted in each group. c, d As-induced mitochon-
drial dysfunction was verified by a decreased cytochrome c oxidase 
(Cox) histochemical staining. c, e Succinate dehydrogenase (SDH) 
histochemical staining. Values are mean ± SD (n = 3), (*) p < 0.05 
versus Con, (**) p < 0.01 versus Con
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TMP prevented As‑triggered the intrinsic apoptotic 
pathway activation in HK‑2 cells
To explore whether sodium arsenite-induced apoptosis in 
HK-2 cells used the intrinsic mitochondrial pathway, the 
protein levels of Bax and Bcl-xl, a pro-apoptotic and an 
anti-apoptotic member, respectively, of the Bcl-2 family, 
were analyzed by Western blotting. Sodium arsenite treat-
ment for 24 h resulted in a reduction of anti-apoptotic Bcl-
xl protein expression and an increase in the pro-apoptotic 
Bax protein expression (Fig. 4a). The decrease in pro-cas-
pase-9 protein levels (that indicated on caspase-9 activa-
tion) and caspase-9/caspase-3-dependent PARP1 cleavage 
induced by sodium arsenite treatment further demonstrated 
the involvement of intrinsic apoptotic pathway (Fig. 4a). 
Co-treatment with TMP (50 and 100 μM) prevented arse-
nic-triggered the intrinsic apoptotic pathway activation, 
and 100 μM TMP showed higher protective efficiency 
(Fig. 4a).
TMP prevented As‑induced HO‑1 activation 
through inhibiting the activation of MAPKs/AP‑1 
pathways
Transcription factor AP-1 interacts with the correspond-
ing binding site in the HO-1 gene promoter region and 
mediates HO-1 expression (Zhang et al. 2006). Further-
more, members of the MAPK family (ERK, JNK and p38) 
contributed to activation of AP-1 (Mossman et al. 2006). 
Thus, we next monitored impact of As on the activation of 
MAPK family and AP-1 in HK-2 cells. As shown in Fig. 4b 
and Fig. 5a, b, As treatment induced MAPK activation (the 
ERK, JNK and p38 MAPK) 3 h after treatment in a dose-
dependent manner. However, individual members showed 
different dynamic changes. Phospho -JNK peaked at 3 h 
and showed the fastest down-regulation, phospho-ERK 
and phospho-p38 MAPK peaked at 6 h. Up-regulation of 
phospho-p38 MAPK was very durable and continued until 
24 h. TMP co-treatment was very effective against As-
induced ERK and MAPK p38 activation, but demonstrated 
only modest effects against JNK activation (Figs. 4b, 5a, 
b). Meanwhile, as an important member of AP-1 family, 
nuclear phospho-c-Jun protein expression increased after 
As exposure in a dose-dependent manner, while both 50 
and 100 μM TMP efficiently inhibited As-induced phos-
pho-c-Jun up-regulation; 100 μM TMP demonstrated 
higher efficiency (Fig. 5c, d).
To further confirm a role of MAPKs in As-induced 
HO-1 expression, small molecule inhibitors of JNK, 
ERK and p38 MAPK were used. As shown in Fig. 6a–c, 
SB203580 (10 μM), an inhibitor of MAPK p38, and 
SP600125 (10 μM), a JNK inhibitor, efficiently down-
regulated HO-1 protein expression induced by 3-h As 
exposure, while pretreatment with ERK inhibitor U0126 
(10 μM) did not affect As-induced HO-1 expression, dem-
onstrating the critical roles for MAPK p38 and JNK in 
Fig. 4  TMP prevented arsenic-triggered activations of the intrinsic 
apoptotic pathway and ERK pathway in HK-2 cells. a As treatment 
(24 h) increased protein levels of pro-apoptotic Bax and pro-cas-
pase-9 expressions and decreased levels of anti-apoptotic Bcl-xl, and 
PARP cleavage, while TMP (50 and 100 μM) pretreatment prevented 
As-triggered the intrinsic apoptotic pathway activation. b As-induced 
ERK activation was verified by increased level of phospho-Thr202/
Tyr204 ERK (p-ERK) expression, which was inhibited by TMP pre-
treatment. β-actin was used as loading control. Values are mean ± SD 
(n = 3)
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As-induced induction of HO-1 protein expression. Mean-
while, both 50 and 100 μM TMP effectively inhibited 
As-induced MAPK activation, and compared with 50, and 
100 μM TMP showed more efficient in inhibiting MAPK 
activation (Figs. 4b, 5a, b).
TMP prevented As‑induced HO‑1 through inhibiting 
the activation of Nrf2 and NF‑κB pathways
Two additional transcription factors, Nrf2 and NF-κB, con-
trol HO-1 gene and protein expression (Garnier et al. 2013; 
Wang et al. 2012; Lim et al. 2014). We monitored Nrf2 and 
phospho-NF-κB p65 (active form) nuclear protein levels 
after As exposure of HK-2 cells. As shown in Fig. 6e, the 
nuclear Nrf2 protein was up-regulated in a dose-depend-
ent manner as early as 3 h after As exposure and peaked 
at 6 h, while the increased expression lasted to 24 h. A 
similar dynamics was previously observed for nuclear 
phospho-NF-κB expression (Gong et al. 2014). To gain 
further insight into the relationship between activation of 
NF-κB p65 and HO-1 up-regulation induced by As expo-
sure, we used co-treatment with Bay11-7082, an inhibitor 
of NF-κB, which selectively and irreversibly inhibits the 
inducible phosphorylation of IκB-α. As shown in Fig. 6d, 
As-induced HO-1 protein expression was strongly down-
regulated by 5 μM Bay11-7082. On the other hand, co-
treatment with TMP partially suppressed As-induced Nrf2 
up-regulation (Fig. 6e). The similar effects of TMP on 
NF-κB activation were previously observed (Gong et al. 
2014).
TMP prevented As‑induced up‑regulation of ARS2 
expression in HK‑2 cells
To elucidate a role of transcription factor ARS2 in arsenic-
induced kidney injury, we determined As-induced protein 
Fig. 5  TMP prevented arsenic-triggered activations of p38 MAPK, 
JNK and c-Jun pathways in HK-2 cells. As-induced JNK (a) and p38 
MAPK (b) activations were verified by increased levels of phospho-
Thr183/Tyr185 MAPK (p-JNK) and phospho-Thr180/Tyr182 p38 
MAPK (p-p38) expression, respectively, which were inhibited by 
TMP pretreatment. c and d 6-h As exposure resulted in nuclear phos-
pho-c-Jun up-regulation, while both 50 and 100 μM TMP efficiently 
inhibited As-induced nuclear c-Jun activation. Histone H3 (Histon) 
and β-actin were used as loading controls for nuclear and total pro-
teins, respectively. Values are mean ± SD (n = 3); (*) p < 0.05 versus 
Con; (**) p < 0.01 versus Con; (#) p < 0.05 versus 2.5 μM As, (##) 
p < 0.01 versus 10 μM As
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expression of ARS2 in HK-2 cells. As shown in Fig. 7a, 
As treatment increased ARS2 protein expression, and such 
an up-regulation was peaking at 6 h and then gradually 
decreased. TMP (100 μM) efficiently inhibited As-induced 
ARS2 up-regulation. Next, to achieve the purpose whether 
MAPKs and NF-κB contributed to As-mediated ARS2 
induction, we used co-treatment with As and specific mole-
cule inhibitors. SB203580 (an inhibitor of p38) and U0126 
(an inhibitor of ERK), but not SP600125 (an inhibitor of 
JNK), obviously inhibited As-induced ARS2 up-regulation 
at 6 h, which indicated MAPK p38 and ERK acted at the 
upstream of ARS2 expression (Fig. 7c–e). Additionally, as 
Fig. 7b demonstrates, Bay11-7082 reversed the effect of As 
on ARS2, which indicated that As-induced ARS2 up-reg-
ulation was also modulated by NF-κB activation in HK-2 
cells.
Discussion
Our previous study (Gong et al. 2014) identified that 
sodium arsenite at a clinically relevant dose also might be 
a risk factor for kidney, while TMP could prevent such an 
As-induced nephrotoxicity by reducing ROS production, 
preventing mitochondria dysfunction and suppressing acti-
vation of pro-inflammatory signals, including β-catenin, 
NF-κB, TNF-α and cyclooxygenase-2 (COX2). How-
ever, the precise renal cellular adaptive mechanism and 
antioxidant-mediated protective responses against arsenic 
exposure with clinically relevant dose are still not clear. In 
the present study, we revealed that clinically relevant con-
centrations of sodium arsenite induced dose-dependent 
and specific activation of MAPKs that further activated 
Fig. 6  TMP prevented arsenic-triggered activation of Nrf2 pathway 
in HK-2 cells; meanwhile, arsenic-induced HO-1 was Nrf2, NF-κB, 
p38 MAPK and JNK dependent. SB203580 (SB) (a), SP600125 
(SP) (b) and Bay11-7082 (Bay) (d), not UO126 (UO) (c), inhibited 
arsenic-induced HO-1 expressions in HK-2 cells. Additionally, TMP 
inhibited arsenic-induced up-regulation of nuclear Nrf2 in HK-2 cells 
(e). Histone H3 (Histon) and β-actin were used as loading controls 
for nuclear and total proteins, respectively. Values are mean ± SD 
(n = 3), (*) p < 0.05 versus Con; (**) p < 0.01 versus Con; (##) 
p < 0.01 versus 10 μM As
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transcription factors Nrf2, NF-κB and AP-1/c-Jun, which 
then control the downstream antioxidant response of HO-1 
in HK-2 cells. Additionally, we observed the up-regulation 
of transcription factor ARS2 expression in this processes, 
which strongly supported the previous speculation about 
essential function of ARS2 (Wilson et al. 2008). Interest-
ingly, TMP inhibited As-induced Nrf2, AP-1 and MAPK 
family activations, accordingly, and reduced HO-1 and 
ARS2 expressions, which might contribute to its nephro-
protective effects.
HO-1 has been identified as a biological hallmark of 
cells in response to unfavorable environment, including 
oxidative stress (Teng et al. 2013; Lee et al. 2012). In our 
previous study (Gong et al. 2014), As exposure dramati-
cally increased cellular ROS production in HK-2 cells, 
and antioxidant NAC and TMP efficiently prevented As-
induced cytotoxicity and ROS production. In the present 
study, the involvement of oxidative stress in As-induced 
nephrotoxicity was further investigated by monitoring 
HO-1 expression. As shown in Fig. 1a, b, we identified the 
induced HO-1 protein expression after As exposure was in 
a dose- and time-dependent manner, whereas the treatment 
of TMP and antioxidant NAC blocked As-induced HO-1 
expression. Such a result also suggested the tight relation-
ship between HO-1 induction and intracellular ROS pro-
duction after arsenite exposure in HK-2 cells. Interestingly, 
aminoguanidine (AG), the inhibitor of iNOS, has no effect 
on the expression of HO-1 in response to As, which sug-
gested that As-induced HO-1 production might mainly be 
mediated by ROS, not nitrosative stress.
Furthermore, a role of HO-1 in As-induced nephrotox-
icity was investigated using ZnPP, a known inhibitor of 
HO-1. Blocking As-induced HO-1 enzymatic activity by 
ZnPP resulted in decreased cell viability (data not shown) 
and promoted As-induced programmed cell death ascer-
tained by increased sub-G1 phase and TUNEL-positive 
Fig. 7  Arsenic-triggered ARS2 expression was NF-κB, p38 MAPK 
and ERK dependent in HK-2 cells. Pretreatment of TMP (a), Bay11-
7082 (Bay) (b), SB203580 (SB) (c) and UO126 (UO) (e), while not 
SP600125 (SP) (d), efficiently inhibited As-induced ARS2 expres-
sion. β-actin was used as loading control for total proteins. Values are 
mean ± SD (n = 3), (*) p < 0.05 versus Con
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cells. Accordingly, cellular ROS production achieved 5.35-
fold increasing, significantly higher than after As treatment. 
Our previous data have confirmed that mitochondrial dam-
age was involved in As-induced nephrotoxicity (Gong et al. 
2014). In the present study, we found that blocking HO-1 
further exacerbated As-induced mitochondrial injury and 
respiratory chain damage, ascertained as a decrease in the 
number of tubular mitochondria and down-regulation in 
Cox expression. All these data mentioned above strongly 
demonstrated that HO-1 played a protective role in As-
induced nephrotoxicity, and blocking HO-1 augmented 
As-induced cell death, ROS production and mitochondrial 
injury. In the other studies, HO-1 also has been shown to 
protect kidney against several acute kidney injury (AKI) 
(Billings et al. 2014; Miyagi et al. 2014; Goodman et al. 
2007).
Nuclear factor erythroid derived-2 (Nrf2) is involved 
in one of the most important cellular defense mecha-
nisms against oxidative stress by regulating cytoprotec-
tive enzymes expressions, for example, HO-1 (Zhang 
et al. 2012; Kilic et al. 2013). Furthermore, Nrf2 has been 
viewed as a protective protein against genotoxic damage. 
Consistent with the above views, there is evidence that 
Nrf2 could protect human bladder urothelial cells (Wang 
et al. 2007) from As toxicity and attenuate hyperglycemia-
induced kidney injury in diabetic mice (Li et al. 2011). 
In contrast, the present study demonstrated that Nrf2 and 
Nrf2-regulated cytoprotective HO-1 genes were activated 
after As exposure at a clinically relevant dose, and such 
an increased expression of Nrf2 and HO-1 failed to rescue 
HK-2 cells from As-induced cytotoxicity. Similar results 
were observed in As-treated oral squamous cells, which 
might suggest that Nrf2- and HO-1-dependent protection 
was overwhelmed by As cytotoxicity (Zhang et al. 2012). 
Indeed, while up-regulation of HO-1 is regarded as cyto-
protective under various experiment conditions, it can be 
non-sufficient to fully recover cells from oxidative damage, 
as shown in our study and other publication (Wang et al. 
2012).
Although many studies highlighted the importance of 
Nrf2 pathway in As-induced HO-1 expression in differ-
ent cell lines (Li et al. 2013; Pi et al. 2008), indeed, the 
mechanisms underlying HO-1 induction are regulated by 
the complex signaling network. In the present study, we 
observed a discrepancy between Nrf2 and HO-1 protein 
expression after As exposure in HK-2 cells: As-induced 
HO-1 expression was in a dose- and time-dependent man-
ner, whereas As-induced Nrf2 expression peaked at 6 h and 
then degraded gradually. Such discrepancy also suggested 
that As might induce HO-1 gene expression through Nrf2-
independent pathways. The previous research suggested 
that Nrf2 played essential role for HO-1 induction only in 
the early and transient phase after As exposure in embry-
onic fibroblasts (Li et al. 2013).
HO-1 induction is tightly regulated primarily at the 
transcriptional level, Nrf2 recruited BRG1 to the HO-1 
enhancers and the promoter, meanwhile, activator protein-1 
(AP-1) and NF-κB located in HO-1 gene promoter region 
(Zhang et al. 2006). Our previous data identified that As 
with clinical dose induced phospho-NF-κB p65 nuclear 
protein (active form) expression in HK-2 cells (Gong et al. 
2014). In the present study, to gain insight into the func-
tional relationship between NF-κB activation and HO-1 
up-regulation in response to As, HK-2 cells were prein-
cubated with Bay11-7082, a specific inhibitor of NF-κB, 
for 30 min followed by 10 μM sodium arsenite treatment 
for 6 h. Figure 6b shows co-treatment of 10 μM sodium 
arsenite and Bay substantially inhibited HO-1 expression 
as compared with As alone, which further indicated that the 
induction of HO-1 expression in As-induced nephrotoxicity 
is through multiple pathways and, at least partially, through 
NF-κB activation.
AP-1 is another transcription factor that could control 
the HO-1 gene expression (Zhang et al. 2006). In addi-
tion, MAPKs contributed to AP-1 induction (Hsieh et al. 
2014). Thus, we next monitored As impact on the activa-
tions of MAPKs and AP-1 and investigated the relation-
ship between MAPKs and HO-1 expression in HK-2 cells. 
As shown in Figs. 4b and 5, arsenic exposure resulted in 
MAPK family activations, which is very consistent to the 
other studies (Wang et al. 2012; Kang et al. 2003), but such 
activation seemed to be cell and species dependent (Wang 
et al. 2012). For example, As exposure only strongly acti-
vated p38 MAPK in normal human lung fibroblast and did 
not activate ERK and JNK (Wang et al. 2013a).
Additionally, the present study established that arse-
nic exposure within clinically relevant dose could activate 
AP-1 family member c-Jun in HK-2 cells (Fig. 5c, d) that is 
very consistent to the previous study (Deshane et al. 2010) 
demonstrating its role for HO-1 induction in renal epithe-
lial cell. Interestingly, only SB203580 (an inhibitor of p38) 
and SP600125 (an inhibitor of JNK), but not U0126 (an 
inhibitor of ERK), efficiently attenuated As-induced HO-1 
production that confirmed only p38 MAPK and JNK, but 
not ERK, contributed to the up-regulation of HO-1 after As 
exposure in HK2 cells.
Taken together, our present data demonstrated that the 
regulation mechanisms of As-induced HO-1 expression 
were performed through multiple signal pathways, Nrf2, 
NF-κB, AP-1, p38 MAPK and JNK.
In our previous study, TMP could reverse the As-
induced sequence of pro-inflammatory signal regulators, 
including NF-κB, p38 MAPK, beta-catenin and COX2, and 
protect HK-2 cells against As-induced programmed cell 
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death (autophagy and apoptosis) (Gong et al. 2014). In cur-
rent study, another novel finding is the demonstration that 
TMP could also suppress the activations of Nrf2, AP-1, 
JNK and ERK after As exposure, accordingly, block HO-1 
protein expression in HK-2 cells. Furthermore, such protec-
tion was performed by preventing As-triggered activation 
of the intrinsic apoptotic pathway. Interestingly, TMP was 
also found to inhibit proliferation of human promyelocytic 
leukemia cell line HL-60 (Wu et al. 2012).
So far, there were no related reports, which focused 
on the effects of As on induction of transcription factor 
ARS2 in As-induced nephrotoxicity. In the present study, 
As treatment increased ARS2 protein expression. Interest-
ingly, the dynamic change in As-induced ARS2 expression 
showed a similar manner with COX2 (Gong et al. 2014). 
Similar to the effects on MAPKs, TMP efficiently inhibited 
ARS2 up-regulation. Nevertheless, attention should be paid 
to the very interesting phenomenon, demonstrating that 
Bay11-7082 (a specific inhibitor of NF-κB), SB203580 (an 
inhibitor of p38) and U0126 (an inhibitor of ERK), but not 
SP600125 (an inhibitor of JNK), attenuate the effects of As 
on ARS2 expression. This indicated that As-induced ARS2 
up-regulation was modulated by the activations of NF-κB, 
p38 MAPK and ERK, but not JNK in HK-2 cells. To our 
knowledge, this is the first report demonstrating that ARS2 
involved in As-induced nephrotoxicity and it was regulated 
by p38 MAPK, ERK and NF-κB. Further studies focusing 
on the potential function of ARS2 in As-induced nephro-
toxicity is worthy of attention.
Although it is not clear which role ARS2 plays in As-
induced nephrotoxicity, but given ARS2 and HO-1 sharing 
the similar regulation mechanism, we thus hypothesize that 
ARS2 and HO-1 might mediate cell survival in response 
to As treatment in HK-2 cells. Previous report also has 
revealed that ARS2 played a role in RNA interference regu-
lation during cell proliferation and in the ability of mam-
malian cells to proliferate (Gruber et al. 2009) that also 
gave the supporting evidence for our speculation of ARS2 
mediating cell survival in As-induced nephrotoxicity in 
HK-2 cells.
In summary, the present study further confirmed that 
arsenic treatment at clinically relevant dose results in renal 
damage, additionally, the activations of Nrf2, AP-1, MAPK 
family and ARS2 involved in such a nephrotoxicity. Fur-
thermore, the cytoprotective HO-1 induction after As 
exposure in HK-2 cells is mediated by multiple pathways, 
including Nrf2, NF-κB, AP-1, p38 MAPK and JNK. The 
current data also demonstrated TMP efficiently reverses 
As-induced Nrf2, NF-κB, AP-1, MAPK family activations 
and blocks the according HO-1 and ARS2 expressions. 
Although further studies are required, we can still propose 
TMP could be effective in the treatment of arsenic-induced 
nephrotoxicity.
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